Over-activation of E2F pathway is also known to be common in human cancers (Chen et al. 2009), and could potentially underlie the upregulation of the NAA40 transcript in several tumour types (Koufaris and Kirmizis 2020). The gene discussed is NAA40; the disease is cancer.